Introduction 47
Dry powder inhalers (DPI) deliver therapeutic agents to the lungs and airways in the form of a 48 powder aerosol. To achieve efficient delivery of these agents to the lungs, perceived wisdom 
107
(ii) inconsistency of drug release from carrier vehicles due to variations of the strength of the 108 inhaled air currents.
Materials and Methods 125

"Transparent" Nexthalers
126
The components of commercial Nexthalers®, (Corradi et al., 2014) , are machine or hand 127 assembled from filled plastic pieces fabricated on multi-cavity tools. To allow the required internal 128 optical access for this study, "transparent" versions were hand assembled from un-filled pieces, of 129 otherwise identical material composition, fabricated using the identical moulding tools and 130 conditions. For the data presented, two Nexthaler devices were used; one for the imaging testing 131 (refilled as required) and one for the velocity measurements. The device incorporates a dose 132 protector, which covers the metered mass of formulation, (dose), released when the device is 133 primed prior to inhalation. It is designed to retract only when the suction produced by the inspiratory 134 effort of the patient reaches the pre-set "trigger" value. As a consequence, the powder dose can 135 only be exposed to a powerful inhaled air current, thereby ensuring its complete fluidisation and 136 efficient dose emission. 
423
The early, small peak (i.e. Peak A in Figure 7 ) occurs 40-50 ms after the suction is switched on for 424 all test conditions, before movement of the dose protector was observed in the high-speed images.
425
As noted earlier, the small quantity of fines emission at this stage will occur as soon as a narrow 426 flow path underneath the dose protector admits sufficient air to pick up fines from the powder dose.
427
However, the intensity data demonstrates the magnitude of this early peak diminishes with 428 increasing rise time. 
